STAB logo

Statera Biopharma (STAB) Short Term Debt

Annual Short Term Debt

$4.83 M
+$2.90 M+149.87%

31 December 2021

STAB Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Short Term Debt

$6.72 M
-$41.20 K-0.61%

30 September 2022

STAB Quarterly Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

STAB Short Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years-+39.1%
5 y5 years+167.7%-

STAB Short Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+149.9%-0.6%+118.1%
5 y5 yearsat high+167.7%-0.6%+526.6%
alltimeall timeat high+167.7%-0.6%+526.6%

Statera Biopharma Short Term Debt History

DateAnnualQuarterly
Sept 2022
-
$6.72 M(-0.6%)
June 2022
-
$6.76 M(+8.2%)
Mar 2022
-
$6.25 M(+29.4%)
Dec 2021
$4.83 M
$4.83 M(+56.7%)
DateAnnualQuarterly
Sept 2021
-
$3.08 M(+187.4%)
June 2021
-
$1.07 M(-44.6%)
Mar 2021
-
$1.93 M(+0.1%)
Dec 2020
$1.93 M(+7.1%)
$1.93 M
Dec 2019
$1.80 M
-

FAQ

  • What is Statera Biopharma annual short term debt?
  • What is the all time high annual short term debt for Statera Biopharma?
  • What is Statera Biopharma quarterly short term debt?
  • What is the all time high quarterly short term debt for Statera Biopharma?

What is Statera Biopharma annual short term debt?

The current annual short term debt of STAB is $4.83 M

What is the all time high annual short term debt for Statera Biopharma?

Statera Biopharma all-time high annual short term debt is $4.83 M

What is Statera Biopharma quarterly short term debt?

The current quarterly short term debt of STAB is $6.72 M

What is the all time high quarterly short term debt for Statera Biopharma?

Statera Biopharma all-time high quarterly short term debt is $6.76 M